MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers

Title
MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers
Authors
Keywords
MDSC, Gemtuzumab, CD33, Cancer, CAR-T
Journal
EBioMedicine
Volume 47, Issue -, Pages 235-246
Publisher
Elsevier BV
Online
2019-08-26
DOI
10.1016/j.ebiom.2019.08.025

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now